Sign Out
Capecitabine is contraindicated in patients with known dihydropyrimidine dehydrogenase (DPD) deficiency.
Capecitabine is contraindicated in patients with severe renal impairment (creatinine clearance below 30mL/min).
Capecitabine is contraindicated in patients with known hypersensitivity to capecitabine or to any of its components.
Capecitabine is contraindicated in patients who have a known hypersensitivity to 5-fluorouracil.
Continue with Google